⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
BCTXW News
BriaCell Therapeutics Corp. Warrant
BriaCell to Present Four Poster Presentations at the 2026 AACR Annual Meeting
globenewswire.com
BCTX
BCTXW
BCTXZ
BCTXL
Form 8-K
sec.gov
BCTXZ
BCTX
BCTXL
BCTXW
Form 8-K
sec.gov
BCTXL
BCTXZ
BCTXW
BCTX
BriaCell and BriaPro Enter Into Asset Purchase Agreement for Exclusive Soluble CD80 License
globenewswire.com
BCTX
BCTXW
BCTXZ
BCTXL
BriaCell Receives Positive Recommendation from Data Safety Monitoring Board (DSMB) for Phase 3 Study in Metastatic Breast Cancer
globenewswire.com
BCTX
BCTXW
BCTXZ
BCTXL
BriaCell Patients’ Images Show Regression and Resolution of Metastasized Tumors and Immune Activation
globenewswire.com
BCTX
BCTXW
BCTXZ
BCTXL
BriaCell Highlights Extended >18-47 Months Survival in Phase 2 Metastatic Breast Cancer Patients
globenewswire.com
BCTX
BCTXW
BCTXZ
BCTXL